Skip to content

A study on the effect of N-acetyl cysteine given around the time of surgery on inflammation and recovery in patients undergoing surgery for perforation peritonitis.

Effect of perioperative intravenous N-Acetyl cysteine on post operative inflammatory response and clinical outcomes in patients undergoing laparotomy for surgical perforation peritonitis: A rabdomized open label controlled trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105590
Enrollment
60
Registered
2026-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K658- Other peritonitis

Interventions

Intervention1: N-ACETYL CYSTEINE DOSING IN THE PERIOPERATIVE PERIOD: Two doses of N-Acetyl cysteine will be given in the peri-operative period. First dose (600mg) after induction of Anaesthesia and se

Sponsors

AIIMS DELHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18 years Confirmed perforation peritonitis requiring laparotomy Informed consent obtained from the patient or legally accepted representative

Exclusion criteria

Exclusion criteria: NAC hypersensitivity Severe Asthma with prior NAC induced bronchospasm Pregnancy/Lactation CKD patient on hemodialysis End stage liver failure Participation in another interventional trial

Design outcomes

Primary

MeasureTime frame
Levels of serum CRP on POD-1 and POD-3 following index laparotomy between the two groupsTimepoint: Post operative day 1 and post operative day 3

Secondary

MeasureTime frame
1) Clavein dindo classification more than grade 3 within 30 days following surgery between the two groups 2) Requirement of new RRT between the two groups within thirty days in the post operative period 3)Length of ICU stay between the two groups 4)Ventilator free days 5)30 day mortality between the two groupsTimepoint: Patients would be followed for 30 days in the post operative period

Countries

India

Contacts

Public ContactDrSai Pavan Ganji

AIIMS DELHI

spvn123@gmail.com9676916702

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026